Latest News
While a healthy lifestyle with regular exercise can improve longevity, the key to ageing well is determined by the brain, says a new paper. Published earlier this month and entitled: ’The Brain Is the Rate-Limiting Organ of Longevity’ it contends that ‘Longevity is not limited by how long the body survives, but by how long [...]
Biological age testing pioneer GlycanAge plans to use the cash raised from its recent US$8.7m funding round to expand its reach, explore additional bio-marking capabilities of its unique technology and fund its recently-opened Californian lab. Agetech World editor Peter McCusker met Jonathan White, head of its UK office, to find out more. GlycanAge was founded [...]
Non-invasive sound stimulation altered Alzheimer’s-linked proteins in aged monkeys in a recent study, with effects lasting more than five weeks. Alzheimer’s involves abnormal amyloid proteins that form plaques and damage synapses, the junctions between nerve cells. Cerebrospinal fluid is the liquid that bathes the brain and spinal cord. In a study of nine rhesus macaques [...]
Veteran male athletes may face higher heart risk during exercise if they have existing heart scarring, new research suggests. The study found that male endurance athletes aged over 50 were more likely to experience abnormal heart rhythms during training if scarring was present. Nine in 10 sudden cardiac deaths during sport occur in older male [...]
Childhood exposure to indoor air pollution may have long-term effects on brain health, with cognitive impairment appearing decades later, new research suggests. The study analysed data from over 7,000 Chinese adults aged 45 and above using machine learning techniques. Nearly 30 per cent of the global population, roughly 2.4bn people, still cook without clean fuels [...]
SimpleC has launched Wellby, an AI companion for unpaid dementia carers, offering round-the-clock emotional support and practical guidance. Announced at CES in Las Vegas, Wellby is designed for caregivers of people with Alzheimer’s disease and related dementias. Some 63 million people in the US provide unpaid care to older adults, including 12 million specifically caring [...]
London-based biotech Engitix has raised US$25m in a Series A extension, with billionaire hedge fund founder Mike Platt backing the company for the second time. The preclinical company is developing therapies that target the extracellular matrix (ECM), the structural material surrounding cells in tissues, in solid tumours and fibrosis. Founder Giuseppe Mazza said the company [...]
TECregen has raised CHF 10m [£9,300,000] in seed financing to develop therapies aimed at rejuvenating the thymus, a gland that produces immune cells. The Basel-based biotechnology company is developing biologics designed to revitalise thymic epithelial cells, which support T-cell production. T-cells are a type of white blood cell crucial for immune function. The thymus shrinks [...]
Corsera Health has raised US$80m in Series A funding to develop preventive RNAi medicines and AI tools to predict and prevent cardiovascular disease. The Boston-based company has begun dosing patients in a Phase 1 clinical trial of COR-1004, a drug designed to lower cholesterol by silencing PCSK9, a gene that regulates LDL cholesterol in the [...]
Captify won AARP’s AgeTech pitch at CES, taking US$10,000 for captioning glasses that show real-time subtitles for people with hearing loss. San Francisco-based Captify beat four other AgeTech firms at the 2026 AgeTech After Dark event. The glasses show captions in the wearer’s field of view and are claimed to be 98 per cent accurate, [...]
